Untargeted metabolomics analysis in 786-O kidney carcinoma cells revealed an impact of EGLN3 depletion on the abundance of different cellular nucleotide components and nucleotide-related structures, such as cytosine and deoxycytidine. Here, EGLN3 is linked to renal carcinoma.